...now PDL BioPharma Inc. (NASDAQ:PDLI), and a $220 million deal with cell separation specialist CellPro Inc....

...director of orthopedic device company Kyphon. Before Kyphon, Murdock was CEO and a director of CellPro...

...autoimmune play Corixa (CRXA); cancer company Seattle Genetics (SGEN); and the now-defunct cell separation play CellPro...
...12 times its original investment - on CellPro. Waite said the firm cashed out before CellPro...

...sites now operating CellPro Inc .’s Ceprate SC devices, which NEXL purchased as part of CellPro’s...

...technical challenge is to culture cells in three dimensions." Goffe previously was a co-founder of CellPro Inc....

...Corp. Its stock will continue to trade on the OTC BB under the symbol CPRO. CellPro Inc....

...Business: Cancer, Cardiovascular Hired: Karen Auditore-Hargreaves as VP of R&D, formerly VP of research at CellPro Inc....

...Amy Ross as VP of diagnostics, formerly senior director of the diagnostics business unit at CellPro Inc. WIR...

...detect and measure low numbers of residual tumor cells to improve cancer treatments. (Appointment, B8) CellPro Inc....

...VP of product and process development, formerly SVP of R&D and engineering and CTO at CellPro Inc. WIR...